These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 9603012)

  • 1. Biochemical analysis associated with HL-60 cells incubated with various ceramic materials.
    Jones L; Tucci M; Benghuzzi H
    Biomed Sci Instrum; 1997; 34():53-8. PubMed ID: 9603012
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of HA, TCP and ALCAP bioceramic capsules on the viability of human monocyte and monocyte derived macrophages.
    Ross L; Benghuzzi H; Tucci M; Callender M; Cason Z; Spence L
    Biomed Sci Instrum; 1996; 32():71-9. PubMed ID: 8672693
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The physiological response associated with large particles of TCP, HA, and ALCAP implants using raw 264.7 cells.
    Thorns M; Benghuzzi H; Tucci M; Cason Z
    Biomed Sci Instrum; 2001; 37():287-92. PubMed ID: 11347404
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bioceramics surface modification by means of osteoclasts in culture.
    Benghuzzi H; Puckett A; Tucci M; Roberts B
    Biomed Sci Instrum; 1999; 35():321-6. PubMed ID: 11143371
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantitative analysis of the cellular components of the fibrous tissue matrix surrounding ALCAP, HA, and TCP bioceramics using adult male rats as a model.
    Butler K; Puckett A; Benghuzzi H
    Biomed Sci Instrum; 1999; 35():267-72. PubMed ID: 11143360
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytological evaluation of the tissue-implant reaction associated with S/C and I/P implantation of ALCAP and HA bioceramics in vivo.
    Butler K; Benghuzzi H; Puckett A
    Pathol Res Pract; 2001; 197(1):29-39. PubMed ID: 11209814
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of a model for bioresorbability of bioceramic microparticles.
    Bell L; Benghuzzi H; Tucci M; Cason Z
    Biomed Sci Instrum; 2001; 37():161-6. PubMed ID: 11347381
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comparison of fibrous tissue formation surrounding intraperitoneal and subcutaneous implantation of ALCAP, HA, and TCP ceramic devices.
    Butler K; Benghuzzi H; Tucci M; Cason Z
    Biomed Sci Instrum; 1997; 34():18-23. PubMed ID: 9603006
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Morphological and biochemical modifications of human macrophages treated with various biomaterials.
    Carr S; Johnston W; Benghuzzi H; Tucci M; Puckett A; Tsao A; Hughes J
    Biomed Sci Instrum; 1999; 35():211-6. PubMed ID: 11143349
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of hydroxyapatite particulate debris on the production of cytokines and proteases in human fibroblasts.
    Ninomiya JT; Struve JA; Stelloh CT; Toth JM; Crosby KE
    J Orthop Res; 2001 Jul; 19(4):621-8. PubMed ID: 11518271
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Biocompatibility of HA/TCP biphasic ceramics with co-cultured human osteoblasts in vitro].
    Lu X; Li S; Zhang J; Zhang Z; Lu B; Bu H; Li Y; Cheng J
    Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2001 Dec; 18(4):497-9. PubMed ID: 11791290
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effects of TCP fabricated with amino acid binders on the proliferation and viability of fibroblast cells.
    Ward J; Cox M; Trussell B; Benghuzzi H; Tucci M; Tsao A; Hughes J
    Biomed Sci Instrum; 2002; 38():197-202. PubMed ID: 12085601
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biochemical markers evaluation of RAW transformed cells during treatment with various biomaterials.
    Johnston W; Carr S; Benghuzzi H; Tucci M; Puckett A; Tsao A; Hughes J
    Biomed Sci Instrum; 1999; 35():217-22. PubMed ID: 11143350
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Controlled release of hydrophilic compounds by resorbable and biodegradable ceramic drug delivery devices.
    Benghuzzi HA; England BG; Bajpai PK
    Biomed Sci Instrum; 1992; 28():179-82. PubMed ID: 1322731
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Successful antidote of multiple lethal infections using sustained delivery of difluoromethylornithine by means of ceramic drug delivery devices.
    Benghuzzi HA; England BG; Bajpai PK; Giffin BF
    Clin Mater; 1994; 15(3):151-60. PubMed ID: 10147210
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term sustained delivery of 3'-azido-2',3'-dideoxythymidine in vivo by means of HA and TCP delivery devices.
    Benghuzzi H
    Biomed Sci Instrum; 2000; 36():343-8. PubMed ID: 10834256
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Micro-particles of bioceramics could cause cell and tissue damage].
    Lu J; Tang T; Ding H; Dai K
    Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2006 Feb; 23(1):85-9. PubMed ID: 16532817
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of TCP sintering temperatures on MRC-5 fibroblast proliferation and viability.
    Cox M; Trussell B; Ward J; Tucci M; Benghuzzi H
    Biomed Sci Instrum; 2002; 38():173-8. PubMed ID: 12085597
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro release of azidothymidine (AZT) by ceramic drug delivery systems.
    Benghuzzi HA; Barbaro RM; Bajpai PK
    Biomed Sci Instrum; 1990; 26():151-6. PubMed ID: 2334759
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Morphometric evaluation of tissue-implant reaction associated with ALCAP and TCP bioceramics in vivo.
    Butler KR; Benghuzzi HA; Puckett A
    J Invest Surg; 2001; 14(3):139-52. PubMed ID: 11453179
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.